A Phase 3b/4 Randomized Double-Blind Placebo Controlled Study Of Methotrexate (Mtx) Withdrawal In Subjects With Rheumatoid Arthritis (Ra) Treated With Tofacitinib 11mg Modified Release (Mr) Formulation.
- Year: 2017
- Type: Musculoskeletal
- Phase: IIIb, IV
- Indication: Rheumatoid Arthritis